US Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881) Meeting Abstract
| Authors: | Barr, P. M.; Li, H. L.; Spier, C. M.; Mahadevan, D.; Friedberg, J. W.; LeBlanc, M. L.; Ul Haq, M.; Flowers, C.; Wagner-Johnston, N. D.; Cheson, B. D.; Horwitz, S. M.; Miller, T. P.; Fisher, R. I. |
| Abstract Title: | US Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204203 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.8523 |
| Notes: | Meeting Abstract: 8523 -- Source: Wos |
